Several studies have demonstrated that αSMA+ CAF depletion led to the increase in colorectal or pancreatic cancer progression using αSMA-tk transgenic mice, thereby leading to specific ablation of proliferating αSMA+ cells [50,51]. The gene discussed is ACTA1; the disease is familial pancreatic carcinoma.